RS-82856, a selective phosphodiesterase inhibitor with inotropic, afterload reduction and antithrombotic properties.
D000818:Animals; D004285:Dogs; D005343:Fibrinolytic Agents; D006339:Heart Rate / Q000187:drug effects*; D007093:Imidazoles / Q000494:pharmacology*; D020105:Milrinone; D010726:Phosphodiesterase Inhibitors; D011728:Pyridones / Q000494:pharmacology; D011799:Quinazolines; D011804:Quinolines / Q000494:pharmacology*; D014664:Vasodilation / Q000187:drug effects
D005343:Fibrinolytic Agents; D007093:Imidazoles; D010726:Phosphodiesterase Inhibitors; D011728:Pyridones; D011799:Quinazolines; D011804:Quinolines; C049443:lixazinone; D020105:Milrinone